Skip to content

PADER (Periodic Adverse Drug Experience Report)

Last reviewed

A Periodic Adverse Drug Experience Report (PADER) is the post-marketing periodic safety report that holders of approved US drug applications submit to the FDA. It is required quarterly for the first three years after approval and annually after that.

Key facts

Regulation21 CFR 314.80(c)(2)
FrequencyQuarterly for three years from approval, then annually
DueWithin 30 days of the close of the quarter; within 60 days of the anniversary date for annual reports
For biologicsPeriodic Adverse Experience Report (PAER), 21 CFR 600.80
AlternativeThe FDA accepts a PBRER in place of the PADER only under a waiver (21 CFR 314.90); its reporting-frequency requirements generally still apply

What a PADER contains

Each report contains a narrative summary and analysis, an analysis of the 15-day Alert reports submitted during the interval, a history of actions taken since the last report because of adverse drug experiences (for example, labeling changes or studies initiated), an index line listing, and individual case safety reports for every adverse drug experience not already reported as a 15-day Alert report.

Sources

Read more